Publication & Citation Trends
Publications
0 total
Patient, Oncologist, and Payer Preferences for Adjuvant Endocrine Therapy and CDK4/6 Inhibitor Regimens in Early-Stage Breast Cancer: A Discrete Choice Experiment OA
Cited by 12
Semantic Scholar
198P Patient & oncologist preferences for adjuvant CDK4/6i therapy in HR+/HER2- early breast cancer OA
Cited by 0
Semantic Scholar
Determination of the Subcellular Localization and Mechanism of Action of Ferrostatins in Suppressing Ferroptosis. OA
Cited by 279
Semantic Scholar
Small molecule modulator of protein disulfide isomerase attenuates mutant huntingtin toxicity and inhibits endoplasmic reticulum stress in a mouse model of Huntington’s disease OA
Cited by 41
Semantic Scholar
FINO2 Initiates Ferroptosis Through GPX4 Inactivation and Iron Oxidation OA
Cited by 634
Semantic Scholar
Lipid peroxidation in cell death. OA
Cited by 1,555
Semantic Scholar
PNAS Plus Significance Statements OA
Cited by 0
Semantic Scholar
A Mitochondrial-Targeted Nitroxide Is a Potent Inhibitor of Ferroptosis OA
Cited by 205
Semantic Scholar
Research Topics
Ferroptosis and cancer prognosis
(4)
Breast Cancer Treatment Studies
(2)
Computational Drug Discovery Methods
(2)
Endoplasmic Reticulum Stress and Disease
(2)
Cancer, Lipids, and Metabolism
(2)
Affiliations
University of Colorado Boulder
Kantar Health (United States)
Columbia University